Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Prioritizing Progressive Supranuclear Palsy: a disease specific mouse tauopathy model
FY 2022-23
Summary
Progressive supranuclear palsy (PSP) is a fatal neurodegenerative disease characterized by the abnormal accumulation of the protein tau in different cell types in select regions of the brain. This toxic accumulation of tau is detrimental to brain function and subsequently human health. PSP has a very distinct pattern of accumulation and spread of tau throughout the brain that underlies the progressive worsening of symptoms and eventually at post-mortem, allows neuropathologists to differentiate it from other diseases that are also impacted by abnormal tau deposition.
A critical barrier preventing our better understanding of the relentless progression of this disease, and our search for a cure, is the lack of an animal model that can replicate these key features of human PSP.
Our study aims to create the first mouse model that reproduces how PSP presents itself in the human brain. To do this, we will use post-mortem brains donated by patients with PSP and selectively analyze brain regions that show deposition of toxic tau protein. We will carefully extract toxic tau protein from those selective human brain regions and inject them in matched regions of the brains of specialized mice that have been adapted to express the same forms of the tau protein that are expressed in the human brain.
If successful, this model can then be used to study:
1) the underlying causes of the deposition of toxic tau in PSP,
2) factors involved in the spread of toxic tau throughout the brain in PSP,
3) future treatments for this incurable and devastating disease.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
486107
Name
Qamar Syeda H
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Prioritizing Progressive Supranuclear Palsy: a disease specific mouse tauopathy model
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Behavioral Analysis; Biochemical Analysis; Cytopathological Analysis; Mouse Models; Neurodegenerative Diseases; Neuropathological Analysis; Progressive Supranuclear Palsy (Psp); Tau
Abstract
Progressive supranuclear palsy (PSP) is a fatal neurodegenerative disease characterized by the abnormal accumulation of the protein tau in different cell types in select regions of the brain. This toxic accumulation of tau is detrimental to brain function and subsequently human health. PSP has a very distinct pattern of accumulation and spread of tau throughout the brain that underlies the progressive worsening of symptoms and eventually at post-mortem, allows neuropathologists to differentiate it from other diseases that are also impacted by abnormal tau deposition.
A critical barrier preventing our better understanding of the relentless progression of this disease, and our search for a cure, is the lack of an animal model that can replicate these key features of human PSP.
Our study aims to create the first mouse model that reproduces how PSP presents itself in the human brain. To do this, we will use post-mortem brains donated by patients with PSP and selectively analyze brain regions that show deposition of toxic tau protein. We will carefully extract toxic tau protein from those selective human brain regions and inject them in matched regions of the brains of specialized mice that have been adapted to express the same forms of the tau protein that are expressed in the human brain.
If successful, this model can then be used to study:
1) the underlying causes of the deposition of toxic tau in PSP,
2) factors involved in the spread of toxic tau throughout the brain in PSP,
3) future treatments for this incurable and devastating disease.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Qamar, Syeda H
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~